5 Best Performing NASDAQ Stocks in 2023

3. MoonLake Immunotherapeutics (NASDAQ:MLTX)

Year To Date Share Price Gains: 410%

MoonLake Immunotherapeutics (NASDAQ:MLTX) is another small biotechnology company. The firm is currently developing a drug that treats inflammatory diseases. It has been doing well on the financial front as of late since the company has beaten analyst EPS estimates in all four of its latest quarters. This seems to have impressed Wall Street, as analysts have rated the shares Strong Buy on average. Furthermore, Wedbush rated the shares as Outperform in October 2023, along with an $86 share price target.

After digging through 910 hedge fund holdings for 2023’s second quarter, Insider Monkey discovered that 29 were the firm’s investors.

Follow Moonlake Immunotherapeutics